Shay Capital’s Spruce Biosciences SPRB Stock Holding History

Shay Capital’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-508	Closed	-$11.1K	–	454
2025 Q1	$11.1K	Hold	508	–	–	﹤0.01%	300
2024 Q4	$16K	Hold	508	–	–	﹤0.01%	293
2024 Q3	$18.1K	Buy	508 +332	+189%	+$12.2K	﹤0.01%	306
2024 Q2	$6.82K	Buy	+176	New	+$9.44K	﹤0.01%	260

Other funds holding SPRB

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

CSC

Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return

Shay Capital's SPRB Position: Q2 2025 in Review

Shay Capital sold out of Spruce Biosciences (SPRB) in Q2 2025, closing a stake of 508 shares — an estimated $11.1K sold.

Shay Capital first reported a position in SPRB in Q2 2024 and held it in 4 quarters. The position peaked at $18.1K in Q3 2024. 3 funds tracked by Wall St. Rank hold SPRB as of Q2 2025.

Shay Capital reported no remaining Spruce Biosciences position as of Q2 2025 after selling out during the quarter.
Shay Capital sold 508 Spruce Biosciences shares in Q2 2025, an estimated $11.1K.
Shay Capital first reported a position in Spruce Biosciences in Q2 2024 and held it in 4 quarters.
Shay Capital's Spruce Biosciences position peaked at $18.1K in Q3 2024.
3 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2025.

Based on Shay Capital's 13F filing for Q2 2025, filed 14 Aug 2025.